Combining Chemistry and Engineering for Hepatocellular Carcinoma: Nano-Scale and Smaller Therapies

Primary liver cancer, or hepatocellular carcinoma (HCC), is a major worldwide cause of death from carcinoma. Most patients are not candidates for surgery and medical therapies, including new immunotherapies, have not shown major improvements since the modest benefit seen with the introduction of sor...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolley, Danielle L., Crouch, Anna Colleen, Özkan, Aliçan, Seeley, Erin H., Whitley, Elizabeth M., Rylander, Marissa Nichole, Cressman, Erik N. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766014/
https://www.ncbi.nlm.nih.gov/pubmed/33419304
http://dx.doi.org/10.3390/pharmaceutics12121243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766014/
https://www.ncbi.nlm.nih.gov/pubmed/33419304
http://dx.doi.org/10.3390/pharmaceutics12121243

Ejemplares similares